Skip to main content

Porphyria Post


Porphyria Post


Member Stories

Share your story! We want to hear from you…

In preparation for Porphyria Awareness Week (April 6-13), the American Porphyria Foundation invites you to share your story with the porphyria community. With permission, all stories will be featured on the APF Website. We will also feature select stories in our quarterly newsletter.

Stories should be about 500 – 2000 words and full of your personality. Make sure to include information about your specific porphyria type, your diagnostic journey and how this disease has impacted your life.

We will be sending out a small token of our appreciation to the first 5 submissions.
We look forward to receiving your stories. The APF office hears regular feedback that the stories listed on our site have helped them feel less isolated and work toward diagnosis. Thank you for having a hand in helping others through your stories and words.

Send your stories to Edrin at edrinw@porphyriafoundation.org


Volunteers Needed!

The APF will be exhibiting at the 2019 ACMG Annual Meeting in Seattle, WA April 3-5. Are you interested in volunteering at our booth? If so, please contact Edrin Williams, Director of Patient Services, for additional information at edrinw@porphyriafoundation.org or 301.347.7166.

This is an incredible opportunity to raise awareness about Porphyria to those with little knowledge about this rare disease.


FDA GRANTS
SCENESSE PRIORITY REVIEW!

Clinuvel Pharmaceuticals announced yesterday that Scenesse has been granted Priority Review by the FDA - the New Drug Application will be reviewed by July 8, 2019. Visit www.clinuvel.com for full information.

The APF and you, the patient community, have been relentless in pursuit of this treatment. Writing letters, making calls, signing petitions, sending photographs, attending meetings - it worked!  

We will continue to focus on this until this treatment is approved and available to all EPP patients in the US. 
ATTENTION SHADOW JUMPERS

Get ready for FIND YOUR SHADOW 2019! The application will be on the APF website starting this Friday, January 11th!

Once again this year, the Shadow Jumpers program will be selecting one family for an all-expenses paid trip to Walt Disney World in Orlando, FL. All children ages 5-17 and their families are eligible to apply. Shadow Jumpers is dedicated to finding creative ways to help kids and their families to take on a safe adventure. 

In 2018, the Stuhlsatz family was selected for Light the Moment 2018, the theme of last year's trip. Their trip - from beginning to end - was "a once in a lifetime experience!"
Shadow Jumpers is excited for your submissions to FIND YOUR SHADOW 2019! 

*please note: Shadow Jumpers is funded through donations and charitable contributions separate from the APF.


Panhematin Study - Participants Needed!
Do you have AIP, VP or HCP? Are you interested in participating in research? If so, we are recruiting volunteers for the Panhematin Study.

Our researchers need people to volunteer for the Panhematin study. Completing this study will help prevent insurance companies from not paying for this treatment.

The purpose of this study is to determine if Panhematin is safe and effective for prevention of acute attacks of porphyria.
·    Can you predict when your next attack will happen?
·    Are you currently receiving prophylactic heme treatment?

Please contact Edrin at the APF office (301.347.7166) if you are interested in participating.


EPP Clinical Trials: Volunteers Needed!
We are close, but we need YOU!

A clinical trial with an oral investigational drug intended to reduce phototoxicity in people living with EPP is underway.

Please note that a Phase 3 study is very unlikely if Phase 2 is not completed. To date, this drug has proven nontoxic and there have been essentially no dropouts in the Phase 2 study to date.

This is an oral drug which makes administration simple.

This study in adults will pave the way for a near-future pediatric trial. EPP is a rare disease and patients must participate in order to get the drug approved. 

To date there is no public information on the availability of Scenesse, and if approved, two drugs on the market may lower their cost.

We will connect you with a Research Coordinator that will answer all your questions and concerns. We will work to make this process as easy as possible for you. 

**Note: If you have not been contacted by a research coordinator please reach out to the APF office at 301.347.7166. **

Eligibility Criteria:
·    Confirmed diagnosis of EPP
·    Provide written informed consent to participate
·    Be willing and able to travel to all study sites for scheduled visits
·    18 - 70 years of age at the time of screening.

Sites enrolling:
·    Mount Sinai - New York City
·    Wake Forest Baptist University - Winston Salem, NC
·    University of Miami - Miami, FL
·    University of Texas Medical Branch - Galveston, TX
·    University of Utah - Salt Lake City, UT
·    University of California San Francisco - San Francisco, CA

We need YOU! Please dig deep and consider being part of this changing moment for all with EPP.

Contact us here at the APF office to get in contact with a research coordinator.
301.347.7166 or 1.866.APF.635

"Remember...Research is the key to YOUR cure!"
Each Step Toward Finding an Effective Treatment is Important!


Harvoni Study - PCT
Harvoni Study - PCT

Do you have PCT? Are you interested in participating in research? Do you have Hepatitis C? If you answered YES to these questions, this is for you.

We need YOU for a clinical trial!

The purpose of this clinical trial is to assess whether Harvoni alone is an effective therapy in active PCT patients with Chronic Hepatitis C.

Who can participate?

1.   Adult patients with PCT who also have Hepatitis C

If you are interested in participating please contact Edrin Williams, Director of Patient Services at the APF office at 301.347.7166 for additional information.




RSVP Today

Patient Education and Support Meeting- Phoenix

LOCATION
Holiday Inn & Suites Phoenix Airport
DATE AND TIME
02/23/19 1:00pm - 02/23/19 3:00pm
3220 S. 48th Street | Phoenix, AZ | Room: Scottsdale | Family and friends are welcome to attend!



Patient Education and Support Meeting- Ann Arbor

LOCATION
Holiday Inn
DATE AND TIME
03/16/19 1:00pm - 03/16/19 3:00pm
3600 Plymouth Road | Ann Arbor, MI | Room: Wolverine A | Family and friends are welcome to attend!





Get Involved



Contact Information

Is your contact information up to date?
If not please give us a call @ 866-APF-3635 or Email to porphyrus@porphyriafoundation.com

American Porphyria Foundation| 1.866.APF.3635 | porphyriafoundation.org

STAY CONNECTED

"Remember....Research is the Key to Your Cure!"


Comments

Popular posts from this blog

WHAT IS NEUROPATHIC PAIN?

What could it be?
Nerve Pain WHAT IS NEUROPATHIC PAIN? Neuropathic or nerve pain (NP) is a long-term or chronic pain disease that results from nerve damage. It can be caused by different diseases or conditions. Worldwide nerve pain affects as many as 26 million people. Neuropathic or nerve pain may affect larger areas of the body or it can be restricted to a smaller area, in this case it is called localized neuropathic pain (LNP). WHAT CAUSES NEUROPATHIC PAIN? Neuropathic or nerve pain may occur in the absence of an obvious visible cause (e.g. an accident, an injury, a chemical burn). There are several external situations that can directly damage nerves and lead to neuropathic pain, such as: Amputation of a limb (phantom pain, stump pain)Surgery (scar pain, post-surgery pain)Trauma or accident Neuropathic pain is also a common complication of other diseases, including nerve damage after shingles or herpes zoster infection (postherpetic neuralgia or PHN), nerve damage after HIV infectio…

GLOBAL PORPHYRIA ALLIANCE

GLOBAL PORPHYRIA ALLIANCE The APF is proud to support our members that live across the globe. Many countries around the world have developed organizations to support their local communities. We hope that enjoy the same opportunity to communicate with one another, develop friendships, and learn about porphyria. Here are links to patient advocacy groups worldwide that offer support to individuals impacted by porphyria. Argentina: Centro de investigaciones sobre porfirinas y porfirias | More informationAustralia: Porphyria Association, Inc. | More informationBrazil: Associação Brasileira de Porfiria | More informationCanada: Canadian Association for Porphyria | More informationColombia: Fundación Colombiana Para La Porfiria | More informationDenmark: Porfyriforeningen.dk (Porphyria Association Denmark)Denmark: Porfyrier.dk (Danish Porphyria Support Group)England: British Porphyria AssociationFinland: Finnish Porphyria Support Group France: Association Française des Malades Atteints de Por…

Happy Winter Season!

                  Happy Winter Season!